| PERIOD ENDING | 29-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 230,271 | 229,395 | 213,690 | 265,983 | | Cost of Revenue | 156,328 | 159,797 | 152,707 | 176,422 | | | Gross Profit | 73,943 | 69,598 | 60,983 | 89,561 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 41,863 | 44,368 | 47,296 | 43,655 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 32,080 | 25,230 | 13,687 | 45,906 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 230 | 552 | 122 | (296) | | Earnings Before Interest And Taxes | 32,310 | 25,782 | 13,809 | 45,610 | | Interest Expense | 316 | 604 | 928 | 1,581 | | Income Before Tax | 31,994 | 25,178 | 12,881 | 44,029 | | Income Tax Expense | 10,669 | 8,121 | 4,096 | 14,888 | | Minority Interest | (42) | (266) | 6 | (81) | | | | Net Income From Continuing Ops | 21,283 | 16,791 | 8,791 | 29,060 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,283 | 16,791 | 8,791 | 29,060 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $21,283 | $16,791 | $8,791 | $29,060 |
|
0.02% Nasdaq 0.00%
Income Statement
